Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism

Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism.

It's the first of the new oral anticoagulants approved to treat deep venous thrombosis or pulmonary embolism...and reduce the risk of a subsequent venous thromboembolism (VTE).

Xarelto has advantages over warfarin for treating venous clots...no anticoag monitoring, fewer interactions, and no bridging with low-molecular-weight heparin because of its fast onset.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote